Design Therapeutics Inc (DSGN) earnings · $214.0M cap
These earnings events as JSON? API free 100/dayDesign Therapeutics Inc (DSGN) is a biotechnology company listed on US.
This DSGN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported DSGN revenue for 2025-12-31 was $0. Net income was -$69.8M. DSGN currently screens at market cap $214.0M.
When the next DSGN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for DSGN. We will not invent a beat or miss.
Not investment advice. Full DSGN research stays on the stock page; the tape stays on the quote page.
DSGN earnings FAQ
What is DSGN's latest net income?
Latest cached Design Therapeutics Inc (DSGN) net income was -$69.8M. Statements: https://lician.com/financials/dsgn
What is DSGN's latest diluted EPS?
Latest cached Design Therapeutics Inc (DSGN) diluted EPS for Dec 31, 2025 was -$1.22.
What period does the latest DSGN earnings print cover?
The latest cached Design Therapeutics Inc (DSGN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are DSGN earnings listed?
Cached earnings facts for Design Therapeutics Inc (DSGN) are listed at https://lician.com/earnings/dsgn. Statements: https://lician.com/financials/dsgn
Not investment advice.